Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for Avricore Health (AVCRF) over the last 11 years, with Q3 2025 value amounting to -$0.0.

  • Avricore Health's EPS (Weighted Average and Diluted) fell 12341.37% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.0, marking a year-over-year decrease of 12341.37%. This contributed to the annual value of $0.0 for FY2024, which is 11735.08% up from last year.
  • Per Avricore Health's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.0 for Q3 2025, which was down 12341.37% from -$0.0 recorded in Q2 2025.
  • Over the past 5 years, Avricore Health's EPS (Weighted Average and Diluted) peaked at $0.0 during Q4 2024, and registered a low of -$0.0 during Q2 2025.
  • Its 4-year average for EPS (Weighted Average and Diluted) is -$0.0, with a median of -$0.0 in 2022.
  • Per our database at Business Quant, Avricore Health's EPS (Weighted Average and Diluted) soared by 12892.35% in 2023 and then crashed by 100354.13% in 2025.
  • Over the past 4 years, Avricore Health's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.0 in 2022, then soared by 128.92% to $0.0 in 2023, then skyrocketed by 31.94% to $0.0 in 2024, then plummeted by 505.03% to -$0.0 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.0 in Q3 2025, compared to -$0.0 in Q2 2025 and $0.0 in Q4 2024.